Pfizer and BioNTech asked the FDA to allow their coronavirus vaccine to be stored for 2 weeks at temperatures typical of conventional pharmaceutical freezers, which could facilitate distribution of the drug. The partners presented data showing that the vaccine is stable at storage temperatures ranging from -25 to -15 degrees Celsius. In the coming weeks, the companies will send similar appeals to other regulators.